76 related articles for article (PubMed ID: 29163158)
1. Shengjiang Xiexin Decoction Alters Pharmacokinetics of Irinotecan by Regulating Metabolic Enzymes and Transporters: A Multi-Target Therapy for Alleviating the Gastrointestinal Toxicity.
Guan HY; Li PF; Wang XM; Yue JJ; He Y; Luo XM; Su MF; Liao SG; Shi Y
Front Pharmacol; 2017; 8():769. PubMed ID: 29163158
[TBL] [Abstract][Full Text] [Related]
2. Sanhuang Xiexin Decoction Ameliorates TNBC By Modulating JAK2-STAT3 and Lipid Metabolism.
Qi Y; Wu XJ; Shi JB; Shi XW; Zhao N; Xiong Y; Wang LP
Chin J Integr Med; 2023 Nov; ():. PubMed ID: 37930511
[TBL] [Abstract][Full Text] [Related]
3. Role of MRPs transporters in pharmacokinetics and intestinal toxicity of irinotecan.
Du T; Luo T; Wang J; Sun R; Cai H
Food Chem Toxicol; 2023 Dec; 182():114171. PubMed ID: 37956707
[TBL] [Abstract][Full Text] [Related]
4. Baicalein, a component of banxia xiexin decoction, alleviates CPT-11-induced gastrointestinal dysfunction by inhibiting ALOX15-mediated ferroptosis.
Pei J; Zou Y; Zhou W; Wang Y
Chem Biol Drug Des; 2023 Dec; 102(6):1568-1577. PubMed ID: 37735740
[TBL] [Abstract][Full Text] [Related]
5. Development of a method to quantify total and free irinotecan and 7-ethyl-10-hydroxycamptothecin (SN-38) for pharmacokinetic and bio-distribution studies after administration of irinotecan liposomal formulation.
Yang W; Yang Z; Liu J; Liu D; Wang Y
Asian J Pharm Sci; 2019 Nov; 14(6):687-697. PubMed ID: 32104495
[TBL] [Abstract][Full Text] [Related]
6. Elucidation of Carboxylesterase Mediated Pharmacokinetic Interactions between Irinotecan and Oroxylin A in Rats via Physiologically Based Pharmacokinetic Modeling.
Zhang J; Zhang Y; Lai YS; Song Q; Xiao M; Ji X; Yan X; Zuo Z
Pharm Res; 2023 Nov; 40(11):2627-2638. PubMed ID: 37667147
[TBL] [Abstract][Full Text] [Related]
7. Tight-Binding Small-Molecule Carboxylesterase 2 Inhibitors Reduce Intracellular Irinotecan Activation.
Kailass K; Casalena D; Jenane L; McEdwards G; Auld DS; Sadovski O; Kaye EG; Hudson E; Nettleton D; Currie MA; Beharry AA
J Med Chem; 2024 Feb; 67(3):2019-2030. PubMed ID: 38265364
[TBL] [Abstract][Full Text] [Related]
8. Covalent CES2 Inhibitors Protect against Reduced Formation of Intestinal Organoids by the Anticancer Drug Irinotecan.
Eades W; Liu W; Shen Y; Shi Z; Yan B
Curr Drug Metab; 2022 Dec; ():. PubMed ID: 36515038
[TBL] [Abstract][Full Text] [Related]
9. An Organ-on-Chip Platform for Simulating Drug Metabolism Along the Gut-Liver Axis.
Lucchetti M; Aina KO; Grandmougin L; Jäger C; Pérez Escriva P; Letellier E; Mosig AS; Wilmes P
Adv Healthc Mater; 2024 Mar; ():e2303943. PubMed ID: 38452399
[TBL] [Abstract][Full Text] [Related]
10. Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics.
de Man FM; Goey AKL; van Schaik RHN; Mathijssen RHJ; Bins S
Clin Pharmacokinet; 2018 Oct; 57(10):1229-1254. PubMed ID: 29520731
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of pharmacological and pharmacokinetic herb-drug interaction between irinotecan hydrochloride injection and Kangai injection in colorectal tumor-bearing mice and healthy rats.
Chen Y; Hu Z; Jiang J; Liu C; Gao S; Song M; Hang T
Front Pharmacol; 2023; 14():1282062. PubMed ID: 38094890
[No Abstract] [Full Text] [Related]
12. Integrated serum pharmacochemistry and metabolomics reveal potential effective components and mechanisms of Shengjiang Xiexin decoction in the treatment of
Cui Y; Zhang C; Zhang X; Yu X; Ma Y; Qin X; Ma Z
Heliyon; 2023 May; 9(5):e15602. PubMed ID: 37206044
[TBL] [Abstract][Full Text] [Related]
13. Gegen Qinlian standard decoction alleviated irinotecan-induced diarrhea via PI3K/AKT/NF-κB axis by network pharmacology prediction and experimental validation combination.
Chen J; Li M; Chen R; Xu Z; Yang X; Gu H; Zhang L; Fu C; Zhang J; Wu Y
Chin Med; 2023 Apr; 18(1):46. PubMed ID: 37106406
[TBL] [Abstract][Full Text] [Related]
14. Variation in the Efficacy of Anti-Ulcerative Colitis Treatments Reveals the Conflict Between Precipitating Compatibility of Traditional Chinese Medicine and Modern Technology: A Case of Scutellaria-Coptis.
Liu D; Zhao R; Wu Y; Wang Y; Yang R; Ke X
Front Pharmacol; 2022; 13():819851. PubMed ID: 35517805
[TBL] [Abstract][Full Text] [Related]
15. Microbiota-Host-Irinotecan Axis: A New Insight Toward Irinotecan Chemotherapy.
Yue B; Gao R; Wang Z; Dou W
Front Cell Infect Microbiol; 2021; 11():710945. PubMed ID: 34722328
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of Shengjiang Xiexin decoction in prophylaxis of chemotherapy-related diarrhea in small cell lung cancer patients: study protocol for a multicenter randomized controlled trial.
Deng C; Lou Y; Gao Y; Deng B; Su F; Jia L
Trials; 2020 May; 21(1):370. PubMed ID: 32357899
[TBL] [Abstract][Full Text] [Related]
17. Jiawei Xianglian Decoction (JWXLD), a Traditional Chinese Medicine (TCM), Alleviates CPT-11-Induced Diarrhea in Mice.
Lu J; Lin Z; Huang S; Shen Y; Jiang J; Lin S
Evid Based Complement Alternat Med; 2020; 2020():7901231. PubMed ID: 32256654
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic incompatibility of the Huanglian-Gancao herb pair.
Zhang JQ; Wang R; Zhou T; Zhao Q; Zhao CC; Ma BL
BMC Complement Med Ther; 2020 Feb; 20(1):61. PubMed ID: 32087732
[TBL] [Abstract][Full Text] [Related]
19. Herbal Medicines for Irinotecan-Induced Diarrhea.
Tang L; Li X; Wan L; Xiao Y; Zeng X; Ding H
Front Pharmacol; 2019; 10():182. PubMed ID: 30983992
[TBL] [Abstract][Full Text] [Related]
20. Chinese Herbal Medicines Facilitate the Control of Chemotherapy-Induced Side Effects in Colorectal Cancer: Progress and Perspective.
Chen D; Zhao J; Cong W
Front Pharmacol; 2018; 9():1442. PubMed ID: 30581388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
